News
Clinical Trials Arena on MSN8h
Daiichi announces first subject dosing in Enhertu trial for endometrial cancerThe study will be carried out in partnership with The GOG Foundation and the European Network of Gynaecological Oncological ...
Pāpāmoa retiree Marion Henriksen was meant to be travelling in Germany and Austria with a friend. Instead, she had to cancel ...
Solventum, a global MedTech leader at the forefront of infection prevention innovation, today announced the launch of its Attesttm Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack.
MyChesCo on MSN2d
ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast CancerThe Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® ...
Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...
The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...
New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback